Have your own idea? Try our Stock Screener
Chinese (SSE) Healthcare Services Industry Analysis
UpdatedSep 26, 2025
DataAggregated Company Financials
Companies41
- 7D-3.0%
- 3M4.0%
- 1Y11.4%
- YTD6.6%
Over the last 7 days, the Healthcare Services industry has dropped 2.8%, driven by pullbacks in Aier Eye Hospital Group and Tibet Rhodiola Pharmaceutical Holding of 1.6% and 10%, respectively. This takes the industry's 12 month performance to a gain of 19%. Earnings are forecast to grow by 20% annually.
Industry Valuation and Performance
Has the Chinese Healthcare Services Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 26 Sep 2025 | CN¥601.5b | CN¥989.5b | CN¥21.7b | 34.2x | 27.7x | 0.6x |
| Sun, 24 Aug 2025 | CN¥624.5b | CN¥988.7b | CN¥20.9b | 33x | 29.9x | 0.6x |
| Tue, 22 Jul 2025 | CN¥591.6b | CN¥988.6b | CN¥20.9b | 32x | 28.3x | 0.6x |
| Thu, 19 Jun 2025 | CN¥558.3b | CN¥988.6b | CN¥20.9b | 29.8x | 26.7x | 0.6x |
| Sat, 17 May 2025 | CN¥565.7b | CN¥992.1b | CN¥21.0b | 31x | 26.9x | 0.6x |
| Mon, 14 Apr 2025 | CN¥555.8b | CN¥985.9b | CN¥20.5b | 30.2x | 27.1x | 0.6x |
| Wed, 12 Mar 2025 | CN¥597.2b | CN¥994.3b | CN¥21.5b | 33.2x | 27.8x | 0.6x |
| Fri, 07 Feb 2025 | CN¥559.3b | CN¥994.3b | CN¥21.5b | 29.3x | 26x | 0.6x |
| Sun, 05 Jan 2025 | CN¥551.0b | CN¥994.3b | CN¥21.5b | 28.8x | 25.6x | 0.6x |
| Tue, 03 Dec 2024 | CN¥634.7b | CN¥994.3b | CN¥21.5b | 35.2x | 29.5x | 0.6x |
| Thu, 31 Oct 2024 | CN¥592.3b | CN¥994.8b | CN¥21.8b | 32.9x | 27.1x | 0.6x |
| Sat, 28 Sep 2024 | CN¥559.1b | CN¥984.5b | CN¥22.0b | 32.4x | 25.4x | 0.6x |
| Mon, 26 Aug 2024 | CN¥478.7b | CN¥987.1b | CN¥22.3b | 23.3x | 21.5x | 0.5x |
| Wed, 24 Jul 2024 | CN¥495.8b | CN¥988.5b | CN¥22.5b | 26.9x | 22x | 0.5x |
| Fri, 21 Jun 2024 | CN¥513.0b | CN¥988.5b | CN¥22.5b | 27.8x | 22.8x | 0.5x |
| Sun, 19 May 2024 | CN¥592.5b | CN¥988.3b | CN¥22.4b | 34.3x | 26.5x | 0.6x |
| Tue, 16 Apr 2024 | CN¥568.5b | CN¥986.3b | CN¥19.4b | 28.7x | 29.3x | 0.6x |
| Thu, 14 Mar 2024 | CN¥625.0b | CN¥977.8b | CN¥20.1b | 29.9x | 31.1x | 0.6x |
| Sat, 10 Feb 2024 | CN¥604.3b | CN¥976.5b | CN¥20.1b | 29.1x | 30.1x | 0.6x |
| Mon, 08 Jan 2024 | CN¥647.3b | CN¥976.7b | CN¥19.7b | 30.1x | 32.9x | 0.7x |
| Wed, 06 Dec 2023 | CN¥701.5b | CN¥976.1b | CN¥19.9b | 31.3x | 35.2x | 0.7x |
| Fri, 03 Nov 2023 | CN¥721.8b | CN¥976.1b | CN¥19.9b | 31.3x | 36.2x | 0.7x |
| Sun, 01 Oct 2023 | CN¥734.1b | CN¥982.2b | CN¥21.2b | 29.8x | 34.7x | 0.7x |
| Tue, 29 Aug 2023 | CN¥710.0b | CN¥965.0b | CN¥23.8b | 21.2x | 29.9x | 0.7x |
| Thu, 27 Jul 2023 | CN¥789.9b | CN¥954.7b | CN¥23.1b | 25.9x | 34.2x | 0.8x |
| Sat, 24 Jun 2023 | CN¥775.4b | CN¥948.1b | CN¥23.0b | 26.1x | 33.7x | 0.8x |
| Mon, 22 May 2023 | CN¥843.2b | CN¥948.0b | CN¥23.0b | 27.1x | 36.7x | 0.9x |
| Wed, 19 Apr 2023 | CN¥855.2b | CN¥914.2b | CN¥26.5b | 32.6x | 32.2x | 0.9x |
| Fri, 17 Mar 2023 | CN¥840.5b | CN¥906.6b | CN¥26.6b | 31.1x | 31.6x | 0.9x |
| Sun, 12 Feb 2023 | CN¥850.4b | CN¥906.0b | CN¥26.4b | 29.6x | 32.2x | 0.9x |
| Tue, 10 Jan 2023 | CN¥811.7b | CN¥905.7b | CN¥26.4b | 29.2x | 30.8x | 0.9x |
| Thu, 08 Dec 2022 | CN¥799.9b | CN¥905.7b | CN¥26.4b | 31.4x | 30.3x | 0.9x |
| Sat, 05 Nov 2022 | CN¥716.6b | CN¥902.4b | CN¥25.8b | 31.4x | 27.7x | 0.8x |
| Mon, 03 Oct 2022 | CN¥655.2b | CN¥842.5b | CN¥23.8b | 21x | 27.5x | 0.8x |
Price to Earnings Ratio
27.5x
Current Industry PE
- Investors are relatively neutral on the Chinese Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 29.4x.
- The industry is trading close to its 3-year average PS ratio of 0.69x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 3.0% per year over the last three years.
- Meanwhile revenues for these companies have grown 5.5% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare industry?
| CN Market | 0.98% | |
| Healthcare | -1.55% | |
| Healthcare Services | -3.00% | |
| Healthcare Facilities | -2.67% | |
| Healthcare Distributors | -3.07% | |
| Healthcare Services | -3.47% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 97.3x.
- Analysts are expecting annual earnings growth of 45.0%, which is higher than its past year's earnings decline of 0.8% per year.
- Investors are most pessimistic about the Healthcare Distributors industry, which is trading close to its 3-year average of 19.1x.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 45% over the next 5 years.
- This is better than its past earnings decline of 0.8% per year.
- In contrast, the Healthcare Distributors industry is expected to see its earnings grow by 9.4% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 000705 Zhejiang Zhenyuan ShareLtd | CN¥10.26 | 6.4% +CN¥207.2m | 30.5% | PE72.2x | |
| 002462 Cachet Pharmaceutical | CN¥14.08 | 3.6% +CN¥142.8m | 19.1% | PE41.2x | |
| 000963 Huadong Medicine | CN¥41.73 | 0.2% +CN¥140.0m | 28.8% | PE20.1x | |
| 002524 Guangzheng Eye Hospital GroupLtd | CN¥4.30 | 2.9% +CN¥61.7m | 12.3% | PS2.6x | |
| 601607 Shanghai Pharmaceuticals Holding | CN¥17.94 | 0.06% +CN¥37.1m | -9.8% | PE11x |